BCM
XYL icon

Bayesian Capital Management’s Xylem XYL Stock Holding History

Bayesian Capital Management’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,800
Closed -$2.92M – 561
2025
Q3 		$2.92M Buy
+19,800
New +$2.75M 0.6% 29
2024
Q3 		– Sell
-23,400
Closed -$3.17M – 1085
2024
Q2 		$3.17M Buy
+23,400
New +$3.18M 0.36% 61
2023
Q2 		– Sell
-31,799
Closed -$3.33M – 1100
2023
Q1 		$3.33M Buy
31,799
+26,800
+536% +$2.8M 0.41% 56
2022
Q4 		$553K Buy
+4,999
New +$524K 0.08% 325
2021
Q4 		– Sell
-5,518
Closed -$682K – 548
2021
Q3 		$682K Buy
+5,518
New +$710K 0.2% 135
2019
Q1 		– Sell
-7,800
Closed -$520K – 791
2018
Q4 		$520K Buy
+7,800
New +$540K 0.11% 276
2018
Q2 		– Sell
-4,227
Closed -$325K – 756
2018
Q1 		$325K Sell
4,227
-10,873
-72% -$804K 0.08% 376
2017
Q4 		$1.03M Sell
15,100
-21,800
-59% -$1.45M 0.21% 166
2017
Q3 		$2.31M Buy
+36,900
New +$2.21M 0.55% 31

Other funds holding XYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bayesian Capital Management's XYL Position: Q4 2025 in Review

Bayesian Capital Management sold out of Xylem (XYL) in Q4 2025, closing a stake of 19,800 shares — an estimated $2.92M sold.

Bayesian Capital Management first reported a position in XYL in Q3 2017 and held it in 9 quarters. The position peaked at $3.33M in Q1 2023. 1,133 funds tracked by Wall St. Rank hold XYL as of Q4 2025.

  • Bayesian Capital Management reported no remaining Xylem position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 19,800 Xylem shares in Q4 2025, an estimated $2.92M.
  • Bayesian Capital Management first reported a position in Xylem in Q3 2017 and held it in 9 quarters.
  • Bayesian Capital Management's Xylem position peaked at $3.33M in Q1 2023.
  • 1,133 funds tracked by Wall St. Rank held Xylem as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.